Amgen (AMGN)
(Delayed Data from NSDQ)
$335.67 USD
+2.53 (0.76%)
Updated Jul 17, 2024 04:00 PM ET
After-Market: $336.00 +0.33 (0.10%) 5:46 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 301 - 320 ( 431 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Repatha Outcomes Met Key Endpoints but Missed Mortality - Hold
Provider: G.RESEARCH, LLC
Analyst: HE J